Cerebrolysin REGistry Study in Stroke - a High-quality Observational Study of Comparative Effectiveness

NCT03480698 · clinicaltrials.gov ↗

COMPLETED

Status

1851

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: Cerebrolysin

Sponsor

Ever Neuro Pharma GmbH

Collaborators

[object Object]